-
Turkey beat US 3-2 with last-gasp winner
-
Venezuelans search for survivors after quakes kill at least 235
-
Asian stocks suffer fresh rout as rollercoaster week draws to close
-
French teen in Singapore straw-licking case to enter plea
-
Japan coach hopes World Cup success can inspire Asian rivals
-
Red rocks yield coveted minerals in DR Congo
-
'Unbearable': tracking heat in one of New Delhi's poorest areas
-
Sony discontinues Japan sales of robot puppy 'aibo'
-
Sheinbaum and King Felipe VI use World Cup to mend diplomatic rift
-
Tunisia boss Renard has 'no regrets' despite World Cup flop
-
Viral bullying videos test Bhutan's digital transition
-
Asian stocks drop again as rollercoaster week draws to close
-
Venezuela races to search for survivors after quakes kill at least 235
-
Court battle plays out over Wimbledon tennis expansion plan
-
Attack on ship in Hormuz leads UN to halt evacuation plan for trapped sailors
-
List of worst World Cup performances
-
Yoon leads Women's PGA Championship, Korda satisfied with 'solid' start
-
NZ internal report warns of Chinese military forays in Pacific
-
Japan to play Brazil in World Cup knockouts after nervy Sweden draw
-
Dutch march into World Cup knockouts as group winners
-
Better to qualify this way, says Ecuador World Cup hero Plata
-
Ivory Coast see 'no limits' after reaching World Cup knockouts for first time
-
Advocaat 'proud' of Curacao as minnows exit World Cup
-
Germany committed 'tactical suicide', says Nagelsmann
-
Iglesias -- Spanish World Cup striker unafraid to speak out about injustice
-
Quake-hit Venezuela's hospitals care for children left alone
-
Anderson to join Man City from Forest for British record fee: reports
-
Cole grabs PGA Travelers lead with Scheffler one back
-
Ecuador upset Germany to reach World Cup last 32 as Curacao eliminated
-
De Silva century rescues Sri Lanka in first Test
-
Ecuador edge Germany to squeeze into World Cup last 32
-
Pepe steers Ivory Coast into World Cup last 32 as Curacao go home
-
Spain women's star Putellas to join London City Lionesses
-
WNBA suspends Thomas for fist to Clark's throat
-
England showing Premier League edge at World Cup: Eze
-
UK'S King Charles breaks precedent to reveal £30 mn paid in taxes since 2022
-
Nasdaq falls again on mixed day for US stocks, oil prices rise
-
Yoon grabs early Women's PGA Championship lead with Korda in hunt
-
France squad look to do grieving Deschamps proud in final World Cup group game
-
Will Taylor Swift and Travis Kelce wed in New York? Clues abound
-
Mayweather's Athens fight with Zambidis is off: report
-
Lawyer says Vondrousova 'should appeal' against four-year ban
-
Alonso committed to Aston Martin, but keeping options open
-
Hospitals raise alert as heatwave slams Europe
-
Events cancelled, records loom as heatwave reaches Germany
-
'Alligator Alcatraz' detention center shuts in US: official
-
Czech striker Schick ends international career
-
Tennis great Evert says 'relentless' cancer has returned
-
US says wants deal with Iran, but not 'at any price'
-
Colombian president-elect gives armed groups one month to surrender
Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care
Peer-reviewed study finds Flo Health's Symptom Checker could deliver nearly $10,100 in net monetary benefit per patient while cutting diagnosis wait time in half
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2026 / Flo Health, the world's #1 women's health app, today announced publication of the first-ever economic evaluation of a digital symptom checker for endometriosis, underscoring the significant financial and health benefits that digital health technology can deliver to women navigating one of the most under-recognized conditions in gynecologic care.
The study, titled "Economic evaluation of a digital symptom checker for endometriosis using a Markov decision process model," and published in npj Digital Medicine, a top peer-reviewed journal in the Nature Portfolio, was conducted in partnership with researchers from The London School of Hygiene & Tropical Medicine and the York Health Economic Consortium. It examined the health and economic outcomes of using Flo Health's Symptom Checker alongside standard care, compared to standard care alone.
Despite affecting approximately 190 million women globally, endometriosis carries an average diagnostic delay of seven years, during which women frequently experience severe menstrual cramps, chronic pelvic pain, and pain during intercourse while receiving insufficient guidance. This delay is associated with increased disease severity, worsening pain, and more complex treatment paths.
The research produced the following key findings:
Women using Flo Health's Symptom Checker alongside standard care received diagnoses in approximately 3 years, compared to the 7-year average under standard care alone, a reduction of more than 50%
Patients gained nearly three weeks of additional healthy life, as measured by quality-adjusted life years (QALYs)
The tool generated approximately $5,196 USD in savings per person over 40 years through reduced medical costs and productivity gains
The total net monetary benefit per patient reached $10,089 USD, based on a willingness-to-pay threshold of $100,000 per QALY, a common benchmark for U.S. institutional payers
"When women are empowered to take control of their health, the benefits go beyond early diagnoses to overall improved physical and emotional well-being," said Dr. Anna Klepchukova, Chief Medical Officer at Flo Health. "This research explores how digital tools may help women better recognize their symptoms and bring clearer insights into conversations with their health care providers."
Flo Health's Symptom Checker is designed as an educational resource that helps users identify symptom patterns that may be consistent with endometriosis, prompting earlier engagement with health care providers. The tool is not intended to diagnose, treat, or replace professional medical care. More than 2.7 million women in the United States have used Flo Health's Symptom Tracker for endometriosis-related support.
Researchers also noted that digital symptom checkers provide the greatest value when tool accuracy exceeds 70%, user compliance surpasses 45%, and outcomes are measured over a minimum 10-year time horizon. The authors indicate that the economic modeling framework applied in this study could be replicated to evaluate digital health tools targeting other conditions that disproportionately affect women and face similar barriers to timely diagnosis.
The publication adds to a growing body of evidence supporting Flo Health's mission to build a better future for female health through trusted, data-backed digital tools. Flo Health currently supports 77 million monthly active users and collaborates with more than 100 medical experts worldwide.
About Flo Health
Flo Health is the leading app in the Health & Fitness category and the #1 OB-GYN-recommended app for period and cycle tracking. As the first European femtech unicorn following a General Atlantic investment in July 2024, Flo Health supports 77 million monthly active users with curated cycle and ovulation tracking, tailored health insights, and a private community for women at every stage of life. Through its Pass it on Project, Flo Health has donated 20 million Premium subscriptions toward its goal of providing 1 billion women in need with free access to health information. For more information, visit flo.health.
PR Contact
Samantha Wannemacher
Flo Health
[email protected]
SOURCE: Flo Health
View the original press release on ACCESS Newswire
E.Rodriguez--AT